Synthetic lipophilic antioxidant BO-653 suppresses HCV replication

Journal of Medical Virology

Volumn 85, Issue 2, 2013, Pages 241-249

  Yasui, Fumihiko ^a   Sudoh, Masayuki ^b   Arai, Masaaki ^c   Kohara, Michinori ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^c MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Antioxidant activity; BO 653; Chemical structure; Chimeric mice; HCV replication

Indexed keywords

4,6 DI TERT BUTYL 2,3 DIHYDRO 5 HYDROXY 2,2 DIPENTYLBENZOFURAN; ANTIOXIDANT; ANTIVIRUS AGENT; PEGINTERFERON ALPHA2A; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIPOPHILICITY; LIVER CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; REPLICON; VIRUS GENE; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; ANTIOXIDANTS; ANTIVIRAL AGENTS; BENZOFURANS; CELL LINE; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; INTERFERON-ALPHA; MICE; RNA, VIRAL; TREATMENT OUTCOME; VIRAL LOAD; VIRUS REPLICATION;

HEPATITIS C VIRUS; MUS;

EID: 84871039541     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23466     Document Type: Article

References (32)

1. Bureau C, Bernad J, Chaouche N, Orfila C, Beraud M, Gonindard C, Alric L, Vinel JP, Pipy B. 2001. Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. J Biol Chem 276:23077-23083.
2. Choi J, Lee KJ, Zheng Y, Yamaga AK, Lai MM, Ou JH. 2004. Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells. Hepatology 39:81-89.
3. Cynshi O, Kawabe Y, Suzuki T, Takashima Y, Kaise H, Nakamura M, Ohba Y, Kato Y, Tamura K, Hayasaka A, Higashida A, Sakaguchi H, Takeya M, Takahashi K, Inoue K, Noguchi N, Niki E, Kodama T. 1998. Antiatherogenic effects of the antioxidant BO-653 in three different animal models. Proc Natl Acad Sci USA 95:10123-10128.
4. Di Bona D, Cippitelli M, Fionda C, Camma C, Licata A, Santoni A, Craxi A. 2006. Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway. J Hepatol 45:271-279.
5. Docherty JJ, Fu MM, Stiffler BS, Limperos RJ, Pokabla CM, DeLucia AL. 1999. Resveratrol inhibition of herpes simplex virus replication. Antiviral Res 43:145-155.
6. Docherty JJ, Sweet TJ, Bailey E, Faith SA, Booth T. 2006. Resveratrol inhibition of varicella-zoster virus replication in vitro. Antiviral Res 72:171-177.
7. Flisiak R, Feinman SV, Jablkowski M, Horban A, Kryczka W, Pawlowska M, Heathcote JE, Mazzella G, Vandelli C, Nicolas-Metral V, Grosgurin P, Liz JS, Scalfaro P, Porchet H, Crabbe R. 2009. The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naive hepatitis C patients. Hepatology 49:1460-1468.
8. Fontaine H, Pol S. 2011. Antiviral activity of telaprevir and boceprevir for the treatment of hepatitis C virus infection in treatment-experienced patients. Clin Res Hepatol Gastroenterol 35:S59-S63.
9. Geiler J, Michaelis M, Naczk P, Leutz A, Langer K, Doerr HW, Cinatl J, Jr. 2010. N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus. Biochem Pharmacol 79:413-420.
10. Gong G, Waris G, Tanveer R, Siddiqui A. 2001. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc Natl Acad Sci USA 98:9599-9604.
11. Ho HY, Cheng ML, Weng SF, Leu YL, Chiu DT. 2009. Antiviral effect of epigallocatechin gallate on enterovirus 71. J Agric Food Chem 57:6140-6147.
12. Huang H, Chen Y, Ye J. 2007. Inhibition of hepatitis C virus replication by peroxidation of arachidonate and restoration by vitamin E. Proc Natl Acad Sci USA 104:18666-18670.
13. Inoue K, Umehara T, Ruegg UT, Yasui F, Watanabe T, Yasuda H, Dumont JM, Scalfaro P, Yoshiba M, Kohara M. 2007. Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo. Hepatology 45:921-928.
14. Kato J, Kobune M, Nakamura T, Kuroiwa G, Takada K, Takimoto R, Sato Y, Fujikawa K, Takahashi M, Takayama T, Ikeda T, Niitsu Y. 2001. Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet. Cancer Res 61:8697-8702.
15. Kumada H, Toyota J, Okanoue T, Chayama K, Tsubouchi H, Hayashi N. 2012. Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan. J Hepatol 56:78-84.
16. Lavanchy D. 2009. The global burden of hepatitis C. Liver Int 29:74-81.
17. Levent G, Ali A, Ahmet A, Polat EC, Aytac C, Ayse E, Ahmet S. 2006. Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy. J Transl Med 4:25.
18. Meng CQ. 2003. BO-653. Chugai. Curr Opin Invest Drugs 4:342-346.
19. Noguchi N, Iwaki Y, Takahashi M, Komuro E, Kato Y, Tamura K, Cynshi O, Kodama T, Niki E. 1997. 2, 3-Dihydro-5-hydroxy-2, 2-dipentyl-4, 6-di-tert-butylbenzofuran: Design and evaluation as a novel radical-scavenging antioxidant against lipid peroxidation. Arch Biochem Biophys 342:236-243.
20. Nourooz-Zadeh J, Tajaddini-Sarmadi J, Wolff SP. 1994. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjuction with triphenylphosphine. Anal Biochem 220:403-409.
21. Sakamoto H, Okamoto K, Aoki M, Kato H, Katsume A, Ohta A, Tsukuda T, Shimma N, Aoki Y, Arisawa M, Kohara M, Sudoh M. 2005. Host sphingolipid biosynthesis as a target for hepatitis C virus therapy. Nat Chem Biol 1:333-337.
22. Seronello S, Sheikh MY, Choi J. 2007. Redox regulation of hepatitis C in nonalcoholic and alcoholic liver. Free Radic Biol Med 43:869-882.
23. Shi ST, Lee KJ, Aizaki H, Hwang SB, Lai MM. 2003. Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2. J Virol 77:4160-4168.
24. Shimoda R, Nagashima M, Sakamoto M, Yamaguchi N, Hirohashi S, Yokota J, Kasai H. 1994. Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res 54:3171-3172.
25. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, Bassendine M, Spengler U, Dore GJ, Powell E, Riordan S, Sheridan D, Smedile A, Fragomeli V, Muller T, Bahlo M, Stewart GJ, Booth DR, George J. 2009. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41:1100-1104.
26. Takeuchi T, Katsume A, Tanaka T, Abe A, Inoue K, Tsukiyama-Kohara K, Kawaguchi R, Tanaka S, Kohara M. 1999. Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology 116:636-642.
27. Tamura K, Kato Y, Ishikawa A, Kato Y, Himori M, Yoshida M, Takashima Y, Suzuki T, Kawabe Y, Cynshi O, Kodama T, Niki E, Shimizu M. 2003. Design and synthesis of 4, 6-di-tert-butyl-2, 3-dihydro-5-benzofuranols as a novel series of antiatherogenic antioxidants. J Med Chem 46:3083-3093.
28. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, Ito Y, Mita E, Tanaka E, Mochida S, Murawaki Y, Honda M, Sakai A, Hiasa Y, Nishiguchi S, Koike A, Sakaida I, Imamura M, Ito K, Yano K, Masaki N, Sugauchi F, Izumi N, Tokunaga K, Mizokami M. 2009. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41:1105-1109.
29. Tian Y, Jiang W, Gao N, Zhang J, Chen W, Fan D, Zhou D, An J. 2010. Inhibitory effects of glutathione on dengue virus production. Biochem Biophys Res Commun 397:420-424.
30. Waris G, Turkson J, Hassanein T, Siddiqui A. 2005. Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: Role of STAT-3 in HCV replication. J Virol 79:1569-1580.
31. Yano M, Ikeda M, Abe K, Dansako H, Ohkoshi S, Aoyagi Y, Kato N. 2007. Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture. Antimicrob Agents Chemother 51:2016-2027.
32. Zhu Z, Wilson AT, Mathahs MM, Wen F, Brown KE, Luxon BA, Schmidt WN. 2008. Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury. Hepatology 48:1430-1439.